about
sameAs
Molecular bases of genetic diversity and evolution of the immunoglobulin heavy chain variable region (IGHV) gene locus in leporids4th Pediatric Allergy and Asthma Meeting (PAAM)A novel functional rabbit IL-7 isoform.Chemokine-mediated B cell trafficking during early rabbit GALT developmentIgH haplotype exclusion in rabbits.In vitro requirement for periostin in B lymphopoiesisSomatically diversified and proliferating transitional B cells: implications for peripheral B cell homeostasis.Bacillus subtilis-mediated protection from Citrobacter rodentium-associated enteric disease requires espH and functional flagella.Analysis of Bacterial Communities during Clostridium difficile Infection in the MouseDiversification of the Primary Antibody Repertoire by AID-Mediated Gene Conversion.Applying refinement to the use of mice and rats in rheumatoid arthritis research.Mechanism for pre-B cell loss in VH-mutant rabbitsInhibition of B Lymphopoiesis by Adipocytes and IL-1-Producing Myeloid-Derived Suppressor CellsA human thymic epithelial cell culture system for the promotion of lymphopoiesis from hematopoietic stem cells.Requirement for BAFF and APRIL during B cell development in GALTB cell development in GALT: role of bacterial superantigen-like molecules.Intestinal bacteria and development of the B-lymphocyte repertoire.B cell and antibody repertoire development in rabbits: the requirement of gut-associated lymphoid tissues.Adipocyte-derived soluble factor(s) inhibits early stages of B lymphopoiesis.Positive selection of the peripheral B cell repertoire in gut-associated lymphoid tissues.Bone marrow fat and the decline of B lymphopoiesis in rabbitsFunctional health literacy and health-promoting behaviour in a national sample of British adults.Development of CD27+ marginal zone B cells requires GALTRoles of the Bacillus anthracis spore protein ExsK in exosporium maturation and germination.Protection from Clostridium difficile infection in CD4 T Cell- and polymeric immunoglobulin receptor-deficient mice.Protection from intestinal inflammation by bacterial exopolysaccharides.Exploring the personal and professional impact of reflective practice groups: a survey of 18 cohorts from a UK clinical psychology training course.Exopolysaccharide from Bacillus subtilis Induces Anti-Inflammatory M2 Macrophages That Prevent T Cell-Mediated Disease.A negative regulatory element in the rabbit 3'IgH chromosomal region.Induction of antitoxin responses in Clostridium-difficile-infected patients compared to healthy blood donors.Functional analysis of I alpha promoter regions of multiple IgA heavy chain genes.Spore formation and toxin production in Clostridium difficile biofilms.B lymphocyte development in rabbit: progenitor B cells and waning of B lymphopoiesis.Allelic variation at the VHa locus in natural populations of rabbit (Oryctolagus cuniculus, L.).Characterization of the T-cell receptor gamma locus and analysis of the variable gene segment expression in rabbit.Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire.Suppression of B lymphopoiesis at a lymphoid progenitor stage in adult rabbits.Inflammatory Changes in Bone Marrow Microenvironment Associated with Declining B Lymphopoiesis.The wide utility of rabbits as models of human diseases.Probiotic exopolysaccharide protects from systemic infection, inducing dual-functioning macrophages that restrict bacterial growth and limit inflammation
P50
Q28728831-7D16B964-7961-4AF2-AC95-FB9093580D23Q28818630-2CDECAFD-E57D-4378-8584-B031833E3E75Q33857243-2924C122-BD87-448B-9328-1DB06A752762Q34646449-780E99A8-52D9-490D-BFB9-EA9FA3E5BD65Q34772069-7834423D-2365-4E8E-8B99-ED0C2416179EQ34870532-2E5D012F-5D3A-4A8B-91E5-A20D1D8AD7B5Q35070232-06F304E1-A364-486B-97BB-81478DF7E1A1Q35689478-AD716D3A-12C3-472F-AFCC-56C35A6B0356Q35760741-6F4B4EEB-C07E-42C4-A57F-E4A3EF705707Q35832563-05710356-A3E0-45E8-8C0E-2327BB1B5724Q35868533-97B6F97F-B428-42F1-9F33-A9701CCEDF1AQ35920333-F23CFE99-F557-410F-B308-E5E41BD74719Q36031591-A38E5021-F21D-49D8-9D0A-010C8C7C1445Q36108839-0A65301C-4750-4C04-BB45-7D07C17B421CQ36135697-0C9109E8-AAA0-4933-8F8C-3FC9A98096A8Q36166756-AE52D3BF-7CC4-44BD-8D80-40E4621008EBQ36168993-CD4AAFEE-20B2-41F4-9EAB-6CD9B20A879DQ36228460-39637477-CD7E-4473-9C85-6AFF72D74F1AQ36353113-0481E917-1ED1-4AF2-9E91-7474AAFD758CQ36402522-05DE7105-EF23-481B-8FB8-01FCE3407D27Q36642445-C00C0C81-ACEB-434F-B754-E1E16885CF43Q36768968-720ACAEE-3237-4E40-8249-979FAD052725Q37132998-563A520A-0DD4-4043-A5D8-45EB7883CC12Q37451608-3F392DE0-94EC-41B9-9AA4-571F15FCE916Q37546363-437A4773-E347-42E0-9598-51D338AA4950Q39534439-FB4FC7C9-D71E-432D-A199-47942CE2AB60Q39926253-A26BE0D9-10BD-459A-87A0-E4879FE5A790Q40331504-2437402D-58BD-4E6D-BBEB-D6282245A535Q40401277-696CEF98-F215-4663-BCD5-87EF6ED5B840Q40610267-D08E10E0-5F2F-4E9E-B0E0-4AC2AE711FC8Q40743311-3C332824-8904-4EFD-816D-FB7AD1A2D400Q41901473-AB2B9AA6-AA4E-4F95-83EE-4E65AFF8F96FQ44684957-5ECAFF5D-9A34-4FFF-8E2B-C28D98CE0CBFQ47283172-71981376-7CC6-4B48-A55E-72FC5DDE6977Q48139885-174301AA-A4BB-4C7B-BA1A-05AFAF884DD9Q48212386-5D507DBD-3D63-4926-9D93-510E1D2F7B36Q50683686-58ADC713-DA96-4C4D-B0D3-66A7BB3B56CEQ51093197-9D8AFE36-7BDE-4902-B1FB-CA984A32379EQ55250836-5B44BD5D-3BF1-4F2B-B458-D31DCEAA7299Q58610415-21E22E02-AB55-4A98-B6D0-243E11110561
P50
description
immunologist
@en
immunoloog
@nl
name
Katherine L. Knight
@ast
Katherine L. Knight
@en
Katherine L. Knight
@es
Katherine L. Knight
@nl
type
label
Katherine L. Knight
@ast
Katherine L. Knight
@en
Katherine L. Knight
@es
Katherine L. Knight
@nl
altLabel
Katherine Knight
@en
Katherine L Knight
@en
prefLabel
Katherine L. Knight
@ast
Katherine L. Knight
@en
Katherine L. Knight
@es
Katherine L. Knight
@nl
P1006
P214
P244
P1006
P106
P1153
7202745496
P21
P213
0000 0000 2484 2027
P214
P244
P31
P496
0000-0003-2108-9457
P734
P735
P7859
lccn-n80127619